Lim, B.; Yoo, D.; Chun, Y.; Go, A.; Kim, J.Y.; Lee, H.Y.; Boohaker, R.J.; Cho, K.-J.; Ahn, S.; Lee, J.S.;
et al. Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301. Cancers 2023, 15, 1737.
https://doi.org/10.3390/cancers15061737
AMA Style
Lim B, Yoo D, Chun Y, Go A, Kim JY, Lee HY, Boohaker RJ, Cho K-J, Ahn S, Lee JS,
et al. Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301. Cancers. 2023; 15(6):1737.
https://doi.org/10.3390/cancers15061737
Chicago/Turabian Style
Lim, Byungho, Dabin Yoo, Younghwa Chun, Areum Go, Ji Yeon Kim, Ha Young Lee, Rebecca J. Boohaker, Kyung-Jin Cho, Sunjoo Ahn, Jin Soo Lee,
and et al. 2023. "Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301" Cancers 15, no. 6: 1737.
https://doi.org/10.3390/cancers15061737
APA Style
Lim, B., Yoo, D., Chun, Y., Go, A., Kim, J. Y., Lee, H. Y., Boohaker, R. J., Cho, K. -J., Ahn, S., Lee, J. S., Jung, D., & Choi, G.
(2023). Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301. Cancers, 15(6), 1737.
https://doi.org/10.3390/cancers15061737